What is a stock summary page? Click here for an overview.
Business Description
Cell Impact
ISIN : SE0017885379
Share Class Description:
FRA:ICLA: Class BCompare
Compare
Traded in other countries / regions
CI.SwedenICLA.Germany IPO Date
2013-03-15Description
Cell Impact develops technologies to produce flow plates for fuel cells. It provides graphite, stainless steel, and titanium flow plates. The company has developed and patented a unique method for high-velocity forming, Cell Impact Forming that makes it possible to produce flow plates with more advanced designs, which in turn creates more cost and energy-efficient fuel cells compared to conventional molding methods.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.66 | |||||
Equity-to-Asset | 0.84 | |||||
Debt-to-Equity | 0.14 | |||||
Debt-to-EBITDA | -0.46 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -3.04 | |||||
Beneish M-Score | 0.24 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -46 | |||||
3-Year EBITDA Growth Rate | 32.8 | |||||
3-Year EPS without NRI Growth Rate | 28 | |||||
3-Year FCF Growth Rate | 45.1 | |||||
3-Year Book Growth Rate | -25.7 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 44.39 | |||||
9-Day RSI | 46.95 | |||||
14-Day RSI | 47.9 | |||||
3-1 Month Momentum % | -14.29 | |||||
6-1 Month Momentum % | -54.2 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.03 | |||||
Quick Ratio | 1.23 | |||||
Cash Ratio | 0.85 | |||||
Days Inventory | 595.92 | |||||
Days Sales Outstanding | 65.25 | |||||
Days Payable | 47.6 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -55.3 | |||||
Shareholder Yield % | -15.76 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 14.51 | |||||
Operating Margin % | -265.29 | |||||
Net Margin % | -270.58 | |||||
FCF Margin % | -224.71 | |||||
ROE % | -38.28 | |||||
ROA % | -31.35 | |||||
ROIC % | -36.08 | |||||
3-Year ROIIC % | -47.37 | |||||
ROC (Joel Greenblatt) % | -41.53 | |||||
ROCE % | -34.12 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.67 | |||||
PB Ratio | 0.33 | |||||
Price-to-Tangible-Book | 0.3 | |||||
EV-to-EBIT | -0.76 | |||||
EV-to-EBITDA | -1.11 | |||||
EV-to-Revenue | 2.04 | |||||
EV-to-FCF | -0.99 | |||||
Price-to-GF-Value | 0.6 | |||||
Price-to-Median-PS-Value | 0.07 | |||||
Earnings Yield (Greenblatt) % | -130.3 | |||||
FCF Yield % | -129.07 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cell Impact Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 3.298 | ||
EPS (TTM) (€) | -0.016 | ||
Beta | 4.05 | ||
3-Year Sharpe Ratio | 0.11 | ||
3-Year Sortino Ratio | 0.36 | ||
Volatility % | 521.5 | ||
14-Day RSI | 47.9 | ||
14-Day ATR (€) | 0.000973 | ||
20-Day SMA (€) | 0.00608 | ||
12-1 Month Momentum % | - | ||
52-Week Range (€) | 0.0017 - 0.041 | ||
Shares Outstanding (Mil) | 696.27 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Cell Impact Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Cell Impact Stock Events
Event | Date | Price (€) | ||
---|---|---|---|---|
No Event Data |
Cell Impact Frequently Asked Questions
What is Cell Impact(FRA:ICLA)'s stock price today?
The current price of FRA:ICLA is €0.01. The 52 week high of FRA:ICLA is €0.04 and 52 week low is €0.00.
When is next earnings date of Cell Impact(FRA:ICLA)?
The next earnings date of Cell Impact(FRA:ICLA) is 2025-05-14 Est..
Does Cell Impact(FRA:ICLA) pay dividends? If so, how much?
Cell Impact(FRA:ICLA) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |